^{International Conference on} Cancer Stem Cells November 18-19, 2020 Lisbon, Portugal

1.            Novel Cancer Immunotherapies

These days, an immune response has been broadly utilized in malignancy treatment. Be that as it may, because of the unpredictability and heterogeneity of malignancy, the obtained obstruction is one of the prime deterrents in the method for disease treatment and the advancement of novel malignant growth immunotherapies with strong antitumor exercises and specificities is desperately required. As of late, the achievement of PD-1/PD-L1 remedial antibodies in the center has uncovered that barricade of tumor-related immunosuppression and commencement of tumor-explicit resistance could be basic for the improvement of novel immunotherapies against malignant growth. The most effective method to productively prompt tumor-explicit insusceptibility would be significant for the improvement of novel malignancy immunotherapies later on.

The top notch unique research articles, just as audit articles, are welcome to comprehend and explain the related information and instrument of antitumor safe reaction and add to the advancement of novel malignancy immunotherapies with high adequacy to instigate antitumor resistance.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

2.            Cancer Genetics and Precision Oncology

Malignant growth is a hereditary malady of physical cells. Tumor karyotypes are once in a while typical, and most show numerous variations from the norm of both number and structure. The principal direct proof for this idea of malignant growth originated from investigations of tumor-explicit translocations in leukemias and lymphomas, uncovering the significance of oncogenes and the guideline of quality translation in disease. A subsequent significant wellspring of data about human malignancy qualities is genetic disease. Hereditary inclination of the autosomal predominant sort forces a high relative hazard for at least one sorts of malignancy. In the previous decade or something like that, in excess of 30 freak qualities for such genetic malignancies have been cloned. Penetrance relies on extra, physical, changes. A couple of the qualities are oncogenes or DNA fix qualities, yet most are tumor silencer qualities. Some tumor silencers control interpretation, while others work in signal transduction pathways that are engaged with managing procedures of cell birth, separation, and passing. The information picked up is animating new ways to deal with the treatment and counteractive action of malignant growth.

Exactness Oncology is an imaginative way to deal with malignant growth treatment that guarantees your treatment is explicitly planned and focused to your remarkable type of disease. It's the study of utilizing every patient's individual hereditary qualities – the qualities that are transformed, making their malignancy develop – to make a treatment convention only for them, in light of those hereditary changes.

At the point when exactness oncology authorities find what quality transformations are really driving your malignancy, they can pick a focused on treatment that will work for those particular changes. Directed treatment (the most recent headway in malignancy treatment) delivers far superior results with fewer reactions than standard chemotherapy.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

3.            Future of Cancer Research

In the course of the most recent two centuries, malignancy treatment has developed from the most crude careful medicines to exceptionally progressed focused on treatments, which work by affecting the procedures that control development, division, and spread of disease cells. Malignant growth investigate is proceeding to progress on numerous fronts, from immunotherapies to robot medical procedures to quality treatments. The war on malignant growth has created huge outcomes:

During the 1970s, around 50 % of individuals determined to have disease made due in any event five years. Presently, more than 66% endure that long.

Today there are in excess of 11 million disease survivors in the United States alone.

Presently, that more individuals are enduring malignant growth, more consideration than any other time in recent memory is cantered around the personal satisfaction and long haul results of disease survivors.

Presently, numerous big names and national pioneers transparently talk about and share their malignancy encounters. The view that malignancy can't be relieved and the feelings of dread that have truly been connected to the sickness are gradually evolving.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

4.            Blastoids, Gastruloids and Organoids

Embryonic foundational microorganisms (ESCs) offer an option and, apparently, the parallel course to analyzing the improvement of developing lives, portraying the procedures and components used physiologically. ESCs is basic during advancement and helpful tentatively, as it averts untimely depletion of the phones as they are cycled into various cell destinies in vivo, and empowers us to culture them inconclusively in the research center. Cautious experimentation has decided a significant number of the qualities and sign engaged with designing the early incipient organism, and it is this well-grounded understanding that empowers us to direct ESCs towards explicit tissue types and cell destinies by applying signals or altering cells' quality articulation in culture.

A striking part of gastruloids (see opening picture) is the finding that they can shape a structure like one that structures just in mammalian developing lives: the node[11]. The hub is a key flagging focus in mammalian incipient organisms and is significant for recognizing which side of the developing life is left or right, and the disturbance of the left-right designing causes extreme birth abandons, typically prompting constant coronary illness. By and by, the best way to think about the impact of left-right pivot interruption is through creature models, so the gastrula framework offers an appealing window into examining this procedure inexpensively and without utilizing creatures.

organoids may have utilized in regenerative prescription. Utilizing cell material from patients through producing iPSCs, a patient's very own cells can be guided towards the necessary cell ancestry or destiny, and the organoids that are framed from this tissue source can be transplanted over into the patient, for example, in the utilization of liver organoids to treat liver cirrhosis [7]. This has the additional advantage of maintaining a strategic distance from tissue dismissal related with transplants from different people and annuls the need for a lifetime of immunosuppressant medications to check organ dismissal.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

5.            Epigenetics and "Maturing"

These epigenetic changes happen at different levels, including decreased mass degrees of the center histones, adjusted examples of histone posttranslational alterations and DNA methylation, supplanting of authoritative histones with histone variations, and modified noncoding RNA articulation, during both organismal maturing and replicative senescence. particular kinds of epigenetic data can work in a transgenerational way to impact the life expectancy of the posterity. A few significant ends rise up out of these examinations: as opposed to being hereditarily foreordained, our life expectancy is to a great extent epigenetically decided; diet and other natural impacts can impact our life expectancy by changing the epigenetic data, and inhibitors of epigenetic proteins can impact the life expectancy of model life forms. These new discoveries give a superior comprehension of the instruments associated with maturing. Given the reversible idea of epigenetic data, these examinations feature energizing roads for remedial intercession in maturing and age-related infections, including malignant growth.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

6.            Stem Cell and Medicine

Foundational microorganism treatment, otherwise called regenerative prescription, advances the fix reaction of ailing, useless or harmed tissue utilizing immature microorganisms or their subsidiaries. It is the following part in organ transplantation and utilizations cells rather than contributor organs, which are constrained in supply.

Analysts develop foundational microorganisms in a lab. These undeveloped cells are controlled to spend significant time in explicit kinds of cells, for example, heart muscle cells, platelets or nerve cells.

The particular cells would then be able to be embedded into an individual. For instance, if the individual has coronary illness, the cells could be infused into the heart muscle. The solid transplanted heart muscle cells could then add to fixing damaged heart muscle.

Specialists have just indicated that grown-up bone marrow cells guided to become heart-like cells can fix heart tissue in individuals, and more research is on-going.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

7.            Neurodegeneration

Neurodegeneration is the dynamic loss of structure or capacity of neurons, including the passing of neurons. Numerous neurodegenerative illnesses – including amyotrophic horizontal sclerosis, Parkinson's infection, Alzheimer's malady, and Huntington's ailment – happen because of neurodegenerative procedures. Such illnesses are hopeless, bringing about dynamic degeneration as well as death of neuron cells.[1] As research advances, numerous likenesses give the idea that relate these infections to each other on a sub-cell level. Finding these likenesses offers trust in helpful advances that could improve numerous infections at the same time. There are numerous parallels between various neurodegenerative issue including atypical protein gatherings just as actuated cell death. Neurodegeneration can be found in a wide range of levels of neuronal hardware going from sub-atomic to fundamental.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

8.            Clinical Trials

The study of clinical preliminaries in oncology developed to incorporate stage I dose‐finding preliminaries, stage II concentrates to set up adequacy in a solitary tumor type, stage III preliminaries contrasting norms of care and potential advances in care, and stage IV concentrates to broaden security and action information in a post‐marketing situation. As an outcome, we can expect higher fix rates in privately restricted tumors and in some metastatic malignant growths. Examiners have generously expanded middle in general endurance measurements for preliminary subjects and patients treated off of preliminaries who have had propelled phases of threatening illnesses.

Endeavors to improve clinical results have brought forth another control of clinical preliminary structure and prompted synergistic scholarly organizations between clinicians, translational researchers, analysts, pharmaceutical organizations, and administrative specialists. At its best, this "concordance of enthusiasm" over the scholarly, clinical, industry and administrative partners has altered disease care and profited humanity. It has spared numerous lives and expanded others, manufactured vocations, prompted colossal and profoundly productive pharmaceutical and restorative gadget enterprises, and expended billions of social insurance dollars.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

9.            Drug Development in Oncology

By and large, medicate advancement is a long procedure in light of the fact that a potential new medication must be recognized and afterward assessed in preclinical and clinical examinations. The disclosure of a potential new medication can happen a few diverse ways.3 Researchers may distinguish another medication by testing various mixes in a lab board to survey for any advantageous impacts, for example, halting malignancy cell development or murdering disease cells.

At times, new comprehension of a malignancy type can prompt sane medication structure, in which a compound is created to focus on a particular malady process. Here and there, existing drugs are found to have a valuable impact against an alternate malignant growth type. At long last, new innovations or potentially detailing plans can change how medications arrive at malignancy cells inside the body, along these lines prompting the capacity to build up an exacerbate that might not have been conceivable already. This underlying procedure is alluded to as target and lead recognizable proof, approval, and optimization.

After introductory testing, any encouraging mixes experience further study in the laboratory. Preclinical considers are led utilizing malignant growth cells and creatures to decide how the compound is best managed and at what portion, its systems of activity, how the body ingests and processes the compound, how it communicates with different medications, and its adequacy contrasted and built up drugs. Animal thinks about are regularly used to decide nitty gritty data about dosing and toxicity.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

10.          3D Bio printing and Bio manufacture

Bio manufacture is insinuated the age of phony tissues or organs to address prosperity challenges in prescription. It every now and again uses the standard of 3D Bio printing to shape cells, gels and strands into an organ.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

11.          Single-cell Genomics

Single cell DNA genome sequencing includes detaching a solitary cell, performing entire genome-intensification (WGA), building sequencing libraries and afterward sequencing the DNA utilizing a cutting edge sequencer (ex. Illumina, Ion Torrent). A genome built in this style is regularly alluded to as a solitary intensified genome or SAG. It tends to be utilized in microbiome considers, so as to get genomic information from uncultured microorganisms. Likewise, it tends to be joined with high throughput cell arranging of microorganisms and malignant growth. One prominent technique utilized for single cell genome sequencing is numerous removal enhancement and this empowers investigation into different regions, for example, microbial hereditary qualities, biology and irresistible sicknesses. Moreover, information acquired from microorganisms may build up forms for refined in the future.[6] Some of the genome get together apparatuses that can be utilized in single cell genome sequencing include: SPAdes, IDBA-UD, Cortex and HyDA.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

12.          Tissue Renewal

The epithelium of the intestinal tract is the most enthusiastically self‐renewing tissue of warm blooded animals with a turnover pace of 5–7 days. To support this, new cells are constantly created by a populace of multipotent intestinal foundational microorganisms that offer ascent to little girl or forebear cells, which can hence separate into the diverse develop cell types. So as to keep up tissue homeostasis, the harmony between intestinal undifferentiated organism’s self‐renewal and separation must be painstakingly directed. This section condenses current comprehension of the personality, area and upkeep of intestinal undeveloped cells and the instruments accessible to consider their conduct in ordinary and neurotic conditions.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

13.          Cancer and its sorts

Cells are the essential units that make up the human body. Cells develop and partition to make new cells as the body needs them. Typically, beyond words they get excessively old or harmed. At that point, new cells have their spot.

Disease starts when hereditary changes meddle with this precise procedure. Cells begin to develop wildly. These phones may shape a mass called a tumor. A tumor can be carcinogenic or kind. A harmful tumor is threatening, which means it can develop and spread to different parts of the body. A kindhearted tumor implies the tumor can develop yet won't spread.

A few sorts of disease don't shape a tumor. These incorporate leukemias, most kinds of lymphoma, and myeloma.

Sorts of malignant growth

Specialists partition malignant growth into types dependent on where it starts. Four fundamental sorts of malignant growth are:

Carcinomas. A carcinoma starts in the skin or the tissue that covers the outside of inner organs and organs. Carcinomas for the most part structure strong tumors. They are the most widely recognized sort of disease. Instances of carcinomas incorporate prostate malignancy, bosom disease, lung malignant growth, and colorectal malignancy.

Sarcomas. A sarcoma starts in the tissues that help and associate the body. A sarcoma can create in fat, muscles, nerves, ligaments, joints, veins, lymph vessels, ligament, or bone.

Leukemias. Leukemia is a disease of the blood. Leukemia starts when sound platelets change and develop wildly. The 4 fundamental sorts of leukemia are intense lymphocytic leukemia, ceaseless lymphocytic leukemia, intense myeloid leukemia, and incessant myeloid leukemia.

Lymphomas. Lymphoma is a disease that starts in the lymphatic framework. The lymphatic framework is a system of vessels and organs that help battle contamination. There are 2 fundamental kinds of lymphomas: Hodgkin lymphoma and non-Hodgkin lymphoma.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

14.          Signalling Pathways and Immuno-oncology

Malignant growth is driven by hereditary and epigenetic modifications that enable cells to overproliferate and escape instruments that ordinarily control their endurance and relocation. Huge numbers of these modifications guide to flagging pathways that control cell development and division, cell passing, cell destiny, and cell motility, and can be set with regards to mutilations of more extensive flagging systems that fuel disease movement, for example, changes in the tumor microenvironment, angiogenesis, and irritation. Transformations that convert cell proto-oncogenes to oncogenes can cause hyperactivation of these flagging pathways, while inactivation of tumor silencers wipes out basic negative controllers of flagging.

Immuno-oncology is the investigation and advancement of medicines that exploit the body's resistant framework to battle disease. Our resistant framework is an intricate system of organs, cells and particles that shields us from remote substances, for example, microscopic organisms and infections—that can cause disease.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

15.          Tumor Evolution, Heterogeneity and Pathways

Tumor movement and presentation to remedial specialists lead to encourage sub-atomic development and heterogeneity that is clinically important. Also, tumors that advance after conclusion and as an element of treatment for the most part become increasingly forceful and recalcitrant to accessible therapeutics, including focused on specialists and immunotherapy. The advancing clinical and atomic heterogeneity of patient tumors can be investigated with different clinical and examine based examples and testing, for example, pre-and post-treatment biopsies; sequential fluid biopsies; single cell examination; PDX and organoid models; anatomic, useful, and sub-atomic imaging; and quick after death contemplates. Different factors that impact tumor heterogeneity incorporate invulnerable checkpoints, malignant growth foundational microorganisms, treatment gained opposition components that may happen through optional transformations, and versatile reactions. Present day technologic propels for tumor portrayal give chances to comprehend tumor advancement and its effect on clinical results to improve remedial regimens. Portrayal of novel targets and advancement of compelling therapeutics are expected to target heterogeneity and the development of obstruction components.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

16.          Vaccines, Adjuvants and Biomarkers

Albeit much progress has been made in the last decade(s) toward advancement of compelling malignancy antibodies, there are as yet significant snags to remedial triumphs. New ages of malignancy antibodies will profit by a mix adjuvant approach that objectives various parts of the invulnerable reaction.

Thus we depict how combinatorial adjuvant systems can help beat significant deterrents to malignancy immunization advancement, including antigen immunogenicity and tumor invulnerable concealment. Tumor antigens might be both tolerogenic and may use dynamic components to smother have insusceptibility, including downregulation of MHC particles to avoid acknowledgment and upregulation of invulnerable inhibitory receptors, to subvert a compelling safe reaction. The present malignant growth immunization writing was overviewed to recognize headways in the comprehension of the organic instruments hidden poor antigen immunogenicity and tumor safe avoidance, just as adjuvant procedures intended to defeat them.

The atomic science of hepato-carcinogenesis has distinguished a few biomarkers, which could give extra data so as to all the more likely comprehend the science of HCC. Countless biomarkers have been appeared to have plausible prescient essentialness and a wide assortment of sub-atomic markers have been demonstrated to be great symptomatic devices for HCC anyway it is difficult to speak to HCC with a solitary biomarker. Subsequently, characteristics of a blend of biomarkers may be progressively significant for the discovering, organizing and perception of HCC. In particular, a connection of HCC-CSCs phenotype to explicit hepatic malignancy subtypes and to explicit clinical and obsessive highlights has not yet been accounted for in human liver tumors.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

17.          Stem Cell and Pathophysiology

Multiplication of the parenchymal cells is directed by various cytokine/development factor-interceded pathways and is convenient synchronized with extracellular grid corruption and the rebuilding of the vasculature. The putative job of undifferentiated organisms in physiology, pathophysiology, and treatment isn't yet exactly known however at present is under escalated examination. The vast majority of distributed information, in any case, presently propose that they don't assume an important job in substitution of epithelial cells in any known type of hepatic damage. In vitro separation conventions for different grown-up extrahepatic undeveloped cells may in the end give important wellsprings of cells to transplantation and treatment.

Amniotic epithelial foundational microorganisms, fatal liver forebear cells just as embryonic undifferentiated organisms as of now rise as elective undeveloped cell sources and open new conceivable outcomes for cell treatments of liver infection.

Related Cancer Conference | Stem Cells Conference | Oncology cultivation Conference | Radiology Conference | Tumor Conference

Cancer stem Cells 2020 welcomes all the attendees, presenters, associations and exhibitors from all over the world to Stockholm, Sweden. We are delighted to invite you all to attend the “International Conference on Cancer and Stem Cells” which is going to be held on November 18-19, Lisbon, Portugal. The congressional committee is gearing up for an exciting and informative conference program including keynote presentations, plenary lectures, young research forum, symposia, and workshops on informative topics, poster presentations and various program for participants from all over the world. We heartily invite participants from all over the globe to take part in Cancer Stem Cells 2020, to share meaningful experience from scholars around the world. We look forward to seeing you in Portugal.

Importance and Scope:

Cancer Stem Cells 2020 with the theme “Expectation and Hype with Innovation and Application” aims to share new ideas and new technologies and to optimize and enhance existing systems and it has the latest Oncology research for in the cancer treatment. Worldwide disease drugs advertise represented $78,238.9 million out of 2016. The malignant growth drugs showcase is driven by the developing pervasiveness of different sorts of disease, expanding request of organic and focused on medication treatments, ceaseless patent expiry of key malignancy drugs and the rising effect of Biosimilars. In any case, the mind-boggling expense of medication advancement, the danger of disappointment and the antagonistic impacts of disease tranquilize treatment, especially chemotherapy, blocks the market development. Created countries have executed severe guidelines for the structure and advancement of disease drugs. USFDA and European Union have embraced noteworthy activities to fuel the development of the malignant growth drugs showcase by giving pre-advertise endorsement to potential medications under clinical improvement. Asia-Pacific and LAMEA are promising districts for directing clinical preliminaries due an extensive populace base and the minimal effort of clinical preliminaries when contrasted with North America and Europe. In any case, headway of malignancy sedate research attributable to natural/directed treatments and customized medications hold promising open doors for pharmaceutical, bio-pharmaceutical and biotechnology organizations occupied with creating disease drugs.

Why Lisbon?

Lisbon is the stunning capital city of Portugal, and is one of the most charismatic and vibrant cities of Europe. It is a city that effortlessly blends traditional heritage, with striking modernism and progressive thinking. As a holiday destination, Lisbon offers a rich and varied history, a buzzing nightlife and is blessed with a glorious year-round climate. Lisbon is a bustling and exciting city that boasts a wide choice of activities and fascinating tourist attractions. The city has a welcoming and liberal atmosphere, while still embracing its deep-rooted heritage and extensive history. Lisbon will appeal to a diverse selection of ages and tourists; it can form a cultural trip, a nightlife extravaganza, a family holiday, a relaxed city-break or even as a base for a beach holiday. Lisbon has hot dry summers, pleasant springs and autumns, and mild, but possibly wet winters. The best time of year to visit Lisbon is in the late spring (May-June) when the days are bright and sunny, but the temperatures are not so high. The peak season is between June and August, and if you visit at this time of year, you should expect the city to feel crowded. The weather is suitable for spending time on the beach from May until the end of September.

Conference Highlights:

Novel Cancer Immunotherapies

Cancer Genetics and Precision Oncology

Future of Cancer Research

Blastoids, Gastruloids & Organoids

Epigenetics and "Aging"

Stem Cell and Medicine

Neurodegeneration

Clinical Trials

Regenerative Medicine and Drug Development in Oncology

3D Bio printing & Bio fabrication

Single-cell Genomics

Tissue Renewal

Cancer and its types

Signalling Pathways and Immune-oncology

Tumour Evolution, Heterogeneity and Pathways

Vaccines, Adjuvants and Biomarkers

Stem Cell and Pathophysiology

Why Attend?

Cancer and Stem Cells 2020 is a platform to meet your target market with individuals from around the globe concentrated on finding out about advertising and showcasing, and insightful leaders through the research talks and presentations and encourage many novel approaches of production and scale-up of Aquaculture Research. It adds a forum for all stakeholders, immense industrialists in the Cancer and Stem Cells sector, original research, featuring review articles, research and development spotlights, news, commentaries, interviews with keynote speakers and much more, with a prospect to building an international community of Cancer and Stem Cells communication.

Members association with Cancer and Stem Cells

The target audience will be Oncologists, Radiologists, Immunologists, Clinical Researchers, Nursing, Malignancy Researchers, Researchers, Undergraduates,  Biomarkers Associations and Societies, Business entrepreneurs, Pharmaceuticals and Diagnostics Companies.   

Major Cancer Associations across the Globe:

American Association for Cancer Research

Virginia Cancer Institute

American Brain Tumour Association

American Society of Paediatric Haematology/Oncology

Association of Cancer Physicians

American Childhood Cancer Organization

American Society of Clinical Oncology

Australasian Lung Cancer Trials Group

International Cancer Research Partnership (ICRP)

American Association for Cancer Research (AACR)

American Society of Clinical Oncology (ASCO)

International Agency for Research on Cancer (IARC)

Cancer Society of New Zealand

Irish Cancer Society

Australian Cervical Cancer Foundation

Medical Centre Cologne

Cancer Research UK

Australian Prostate Cancer Research

Peter McCollum Cancer Centre

The European Cancer Organization (ECCO)

German Cancer Research Centre

Major Medical Universities: Worldwide

Harvard University

University of Minnesota

Mayo Medical School

Pittsburgh School of Medicine

Yale University

University of Cambridge

University of Oxford Stanford University

Yale University

Emory University

John Hopkins University

Kings College London

Feinberg School of Medicine

University of Wisconsin

UNC School of Medicine

Karolinska University

The University of Tokyo

National University of Singapore (NUS)

Kyoto University

University of Hong Kong (HKU)

Peking University

Seoul National University (SNU)

National Taiwan University (NTU)

Osaka University

Tsinghua University0

The Chinese University of Hong Kong (CUHK)

Fudan University

The Hong Kong University of Science and Technology (HKUST)

Taipei Medical University

Mahidol University

KAIST - Korea Advanced Institute of Science and Technology

Yonsei University

Shanghai Jiao Tong University

Nanyang Technological University (NTU)

Chulalongkorn University

Tohoku University

Tokyo Medical and Dental University

Kyushu University

Nagoya University

Hokkaido University

Sungkyunkwan University

University of Science and Technology of China

Pohang University of Science and Technology (POSTECH)

Korea University

Universiti Malaya (UM)

Zhejiang University

Keio University

Indian Institute of Science

University of Tsukuba

University of Delhi

A Unique Opportunity for Advertisers and Sponsors at this International event:

Cancer is one of the most communal reasons of deaths crosswise the biosphere. The extraordinary occurrence of numerous kinds of cancer, such as breast cancer, bladder cancer, lung cancer, leukaemia, pancreatic cancer, as well as prostate cancer, has enlarged the death rate crosswise the world. Nations such as Hungary, Netherlands, Denmark, and Croatia have observed a growth in the volume of cancer circumstances over the past few years. The growing instances of cancer-related morbidity across the world will fuel the request for cancer stem cell therapeutics and determination the development of the worldwide cancer stem cell treatment marketplace size at a CAGR of over 11% throughout the projection dated. The global cancer stem cells market size was valued at USD 679.5 million in 2016the global cancer stem cell therapeutics market to grow at a CAGR of over 11%% during the period 2019-2023.currently, oncology therapeutics has entered a new era with conventional therapies such as radiotherapy, chemotherapy, & surgeries on one side and stem cell therapies on another side.

Market value on Cancer Stem Cells:

Cancer is second leading cause of death worldwide. Treatments that work for some cancers don’t work for the others and sometimes those treatments simply stop working and only a global search for answers will help us get to grip this disease. The conference will provide with an opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of oncology.

Meet your target market

The peoples from around the globe are focusing on learning the overview and techniques of Cancer and Stem Cells. So here is the opportunity to reach the largest group of a participant from around the world for grasping the knowledge of different field on a single platform. The conference will conduct Keynote presentations, Oral talks (Speaker forum and Young research forum), Poster presentations, Workshops and Exhibitions and receive a participation certificate at the 2 days event.

Planning a Trip to Lisbon?? Attend our Meeting!!!

An issue with VISA!!

Cancer stem cells 2020 Committee will be glad to help you in all regards to plan your trip to Lisbon, Portugal. Get the official invitation letter from us to attend this event and ahead with a closer step for approval of your VISA

For further Information Mail to contact@europemeet.com

City Attractions of Lisbon:

•Wonder at the Torre de Belem

•Ride Tram 28

•Get lost in the Alfama District

•Make a trip to Sintra

•Enjoy the azulejos in the National Tile Museum

•Conquer the bulwarks of St George’s Castle

•Trace glorious history in the Monastery of Jerónimos

•Go underwater in the Lisbon Oceanarium

•Wonder at the master works of the National Museum of Ancient Art

•Get a taste of the East in Museu do Oriente

•Hop aboard the funiculars

•Enjoy the Mercado da Ribeira

•People watch on the Rossio

•Enjoy the modern Berardo Collection Museum

•Eat and drink in the Bairro Alto and many more….

NOTE: A letter of invitation is proof that your registration application is accepted by the conference committee board. It will be stated in English and may help you with the Visa Application. However, it does not guarantee you a Visa.

An invitation letter will only be issued once your registration and payment have been completed.

PRESENTATION REQUIREMENTS:

• Presenting authors are responsible for registration, travel, and hotel costs. Note: Those with accepted abstracts will receive an acceptance mail allowing them to register for the conference.
• Abstracts will be compiled and conference books are made available to participants at the conference.
• Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

SUBMISSION OPTIONS:

• Oral paper presentations will have 30-minute time slots and be clustered by theme into sessions. The keynote session will have for a 45-minute time slot, workshop/ special session will have a 60-minute time slot and symposium will have 60-minute time slot followed by 5-minute Q&A session.
• Graduate & Masters students are eligible to submit their abstracts under poster and e-poster presentation category.
• PhD students are eligible to submit their abstract under special YRF (young researcher’s forum), poster and e-poster presentation category.

NOTE: YRF category includes short oral presentation especially for Ph. D. students

• Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

Submission Deadlines

Early Bird Abstract Submission: December 31, 2019

Second Line Abstract Submission: June 01, 2020

Final Submission Deadline: October 10, 2020

Registration Deadlines

Early Bird:  January 10, 2020

Second Round: July 10, 2020                                                          

Final Registration: November 18, 2020

World Cancer Summit 2018

Cancer Summit 2018 meeting has given us the prospect to bring the event once again. Conference series LLC Ltd facilitated the "World Cancer Summit 2018" amid July 02-03, 2018, Bangkok, Thailand.

The meeting was centred on finding out about Oncologists with the topic "Exploring the possibilities in closing the era of Cancer". The gathering chiefly coordinates towards tending to primary issues like Prevention, Diagnosis, and Treatment infections of the Organ-related Cancers and its inventive methods. Cancer Summit 2018 is a champion among the most reviving Cancer Conferences dealt with by Conference series LLC Ltd.

This Cancer Summit 2018 was discussed on procedures and strategies related to organization, quality difference in Cancer and to explore the new contemplations and thoughts on overall scale and the focuses join lung tumour, bosom danger, bone development, cervical development, colon-rectum infection, prostate tumour, thyroid tumour. The gathering was set out with an opening function took after by Sessions and took after by arrangement of addresses conveyed by both Honourable Guests and individuals from the Keynote discussion. The adepts who declared the topic with their impeccable talk were:

Shashikant Limbachiya, Narayana Multispecialty Hospital, India

Dagmara Poprawski,   Country Health South Australia Local Health Network, Australia

Jang Mi Han, Sun Moon University South Korea

Haet Nim Lim, Sun Moon University South Korea

Kuo-Wang Tsai, Sun Moon University South Korea

Dariusz Borys, Loyola University Chicago, USA

Lyudmila Severyanova, Kursk State Medical University, Russian Federation

Anshoo Agarwal, Northern Border University, Kingdom of Saudi Arabia

Nor Ashikin Mohamed Noor Khan, Universiti Teknologi MARA, Malaysia

SIN Chun Fung, University of Hong Kong, Hong Kong

Conference Series LLC Ltd offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference Series LLC Ltd and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Cancer Summit 2018, Conference Series LLC Ltd would like to announce the of the “International Conference on Cancer and Stem Cells, during November 18-19, 2020 Lisbon, Portugal.

For more details: https://cancerstemcells.conferenceseries.com/

Let us meet again @cancer stem cells 2020